Global Enterovirus Vaccine Market Insights, Forecast to 2029
This report presents an overview of global market for Enterovirus Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Enterovirus Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Enterovirus Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Enterovirus Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Enterovirus Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Enterovirus Vaccine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sinovac Biotech, Medigen Vaccine Biologics, Shenzhen Neptunus, Sinopharm, Adimmune, Intravacc, Shanghai Zerun Biotechnology and Beijing Minhai Biotechnology, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Enterovirus Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Enterovirus Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Enterovirus Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
This report researches the key producers of Enterovirus Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Enterovirus Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Enterovirus Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Enterovirus Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Enterovirus Vaccine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sinovac Biotech, Medigen Vaccine Biologics, Shenzhen Neptunus, Sinopharm, Adimmune, Intravacc, Shanghai Zerun Biotechnology and Beijing Minhai Biotechnology, etc.
By Company
- Sinovac Biotech
- Medigen Vaccine Biologics
- Shenzhen Neptunus
- Sinopharm
- Adimmune
- Intravacc
- Shanghai Zerun Biotechnology
- Beijing Minhai Biotechnology
- Coxasckievirus A
- Coxasckievirus B
- Human Enterovirus 71
- Others
- Hospital
- Research Institute
- Others
- US & Canada
- U.S.
- Canada
- China
- Asia (excluding China)
- Japan
- South Korea
- China Taiwan
- Southeast Asia
- India
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Middle East, Africa, Latin America
- Brazil
- Mexico
- Turkey
- Israel
- GCC Countries
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Enterovirus Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Enterovirus Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Enterovirus Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 STUDY COVERAGE
1.1 Enterovirus Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Enterovirus Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Coxasckievirus A
1.2.3 Coxasckievirus B
1.2.4 Human Enterovirus
1.2.5 Others
1.3 Market by Application
1.3.1 Global Enterovirus Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Research Institute
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Enterovirus Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Enterovirus Vaccine Revenue by Region
2.2.1 Global Enterovirus Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Enterovirus Vaccine Revenue by Region (2018-2023)
2.2.3 Global Enterovirus Vaccine Revenue by Region (2024-2029)
2.2.4 Global Enterovirus Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Enterovirus Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Enterovirus Vaccine Sales by Region
2.4.1 Global Enterovirus Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Enterovirus Vaccine Sales by Region (2018-2023)
2.4.3 Global Enterovirus Vaccine Sales by Region (2024-2029)
2.4.4 Global Enterovirus Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 COMPETITION BY MANUFACTURES
3.1 Global Enterovirus Vaccine Sales by Manufacturers
3.1.1 Global Enterovirus Vaccine Sales by Manufacturers (2018-2023)
3.1.2 Global Enterovirus Vaccine Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Enterovirus Vaccine in 2022
3.2 Global Enterovirus Vaccine Revenue by Manufacturers
3.2.1 Global Enterovirus Vaccine Revenue by Manufacturers (2018-2023)
3.2.2 Global Enterovirus Vaccine Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Enterovirus Vaccine Revenue in 2022
3.3 Global Key Players of Enterovirus Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Enterovirus Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Enterovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Enterovirus Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Enterovirus Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Enterovirus Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE
4.1 Global Enterovirus Vaccine Sales by Type
4.1.1 Global Enterovirus Vaccine Historical Sales by Type (2018-2023)
4.1.2 Global Enterovirus Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Enterovirus Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Enterovirus Vaccine Revenue by Type
4.2.1 Global Enterovirus Vaccine Historical Revenue by Type (2018-2023)
4.2.2 Global Enterovirus Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Enterovirus Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Enterovirus Vaccine Price by Type
4.3.1 Global Enterovirus Vaccine Price by Type (2018-2023)
4.3.2 Global Enterovirus Vaccine Price Forecast by Type (2024-2029)
5 MARKET SIZE BY APPLICATION
5.1 Global Enterovirus Vaccine Sales by Application
5.1.1 Global Enterovirus Vaccine Historical Sales by Application (2018-2023)
5.1.2 Global Enterovirus Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Enterovirus Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Enterovirus Vaccine Revenue by Application
5.2.1 Global Enterovirus Vaccine Historical Revenue by Application (2018-2023)
5.2.2 Global Enterovirus Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Enterovirus Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Enterovirus Vaccine Price by Application
5.3.1 Global Enterovirus Vaccine Price by Application (2018-2023)
5.3.2 Global Enterovirus Vaccine Price Forecast by Application (2024-2029)
6 US & CANADA
6.1 US & Canada Enterovirus Vaccine Market Size by Type
6.1.1 US & Canada Enterovirus Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Enterovirus Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Enterovirus Vaccine Market Size by Application
6.2.1 US & Canada Enterovirus Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Enterovirus Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Enterovirus Vaccine Market Size by Country
6.3.1 US & Canada Enterovirus Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Enterovirus Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Enterovirus Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 EUROPE
7.1 Europe Enterovirus Vaccine Market Size by Type
7.1.1 Europe Enterovirus Vaccine Sales by Type (2018-2029)
7.1.2 Europe Enterovirus Vaccine Revenue by Type (2018-2029)
7.2 Europe Enterovirus Vaccine Market Size by Application
7.2.1 Europe Enterovirus Vaccine Sales by Application (2018-2029)
7.2.2 Europe Enterovirus Vaccine Revenue by Application (2018-2029)
7.3 Europe Enterovirus Vaccine Market Size by Country
7.3.1 Europe Enterovirus Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Enterovirus Vaccine Sales by Country (2018-2029)
7.3.3 Europe Enterovirus Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 CHINA
8.1 China Enterovirus Vaccine Market Size
8.1.1 China Enterovirus Vaccine Sales (2018-2029)
8.1.2 China Enterovirus Vaccine Revenue (2018-2029)
8.2 China Enterovirus Vaccine Market Size by Application
8.2.1 China Enterovirus Vaccine Sales by Application (2018-2029)
8.2.2 China Enterovirus Vaccine Revenue by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Enterovirus Vaccine Market Size by Type
9.1.1 Asia Enterovirus Vaccine Sales by Type (2018-2029)
9.1.2 Asia Enterovirus Vaccine Revenue by Type (2018-2029)
9.2 Asia Enterovirus Vaccine Market Size by Application
9.2.1 Asia Enterovirus Vaccine Sales by Application (2018-2029)
9.2.2 Asia Enterovirus Vaccine Revenue by Application (2018-2029)
9.3 Asia Enterovirus Vaccine Sales by Region
9.3.1 Asia Enterovirus Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Enterovirus Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Enterovirus Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 MIDDLE EAST, AFRICA AND LATIN AMERICA
10.1 Middle East, Africa and Latin America Enterovirus Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Enterovirus Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Enterovirus Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Enterovirus Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Enterovirus Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Enterovirus Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Enterovirus Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Enterovirus Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Enterovirus Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Enterovirus Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 COMPANY PROFILES
11.1 Sinovac Biotech
11.1.1 Sinovac Biotech Company Information
11.1.2 Sinovac Biotech Overview
11.1.3 Sinovac Biotech Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Sinovac Biotech Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sinovac Biotech Recent Developments
11.2 Medigen Vaccine Biologics
11.2.1 Medigen Vaccine Biologics Company Information
11.2.2 Medigen Vaccine Biologics Overview
11.2.3 Medigen Vaccine Biologics Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Medigen Vaccine Biologics Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Medigen Vaccine Biologics Recent Developments
11.3 Shenzhen Neptunus
11.3.1 Shenzhen Neptunus Company Information
11.3.2 Shenzhen Neptunus Overview
11.3.3 Shenzhen Neptunus Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Shenzhen Neptunus Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Shenzhen Neptunus Recent Developments
11.4 Sinopharm
11.4.1 Sinopharm Company Information
11.4.2 Sinopharm Overview
11.4.3 Sinopharm Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Sinopharm Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sinopharm Recent Developments
11.5 Adimmune
11.5.1 Adimmune Company Information
11.5.2 Adimmune Overview
11.5.3 Adimmune Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Adimmune Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Adimmune Recent Developments
11.6 Intravacc
11.6.1 Intravacc Company Information
11.6.2 Intravacc Overview
11.6.3 Intravacc Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Intravacc Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Intravacc Recent Developments
11.7 Shanghai Zerun Biotechnology
11.7.1 Shanghai Zerun Biotechnology Company Information
11.7.2 Shanghai Zerun Biotechnology Overview
11.7.3 Shanghai Zerun Biotechnology Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Shanghai Zerun Biotechnology Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Shanghai Zerun Biotechnology Recent Developments
11.8 Beijing Minhai Biotechnology
11.8.1 Beijing Minhai Biotechnology Company Information
11.8.2 Beijing Minhai Biotechnology Overview
11.8.3 Beijing Minhai Biotechnology Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Beijing Minhai Biotechnology Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Beijing Minhai Biotechnology Recent Developments
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
12.1 Enterovirus Vaccine Industry Chain Analysis
12.2 Enterovirus Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Enterovirus Vaccine Production Mode & Process
12.4 Enterovirus Vaccine Sales and Marketing
12.4.1 Enterovirus Vaccine Sales Channels
12.4.2 Enterovirus Vaccine Distributors
12.5 Enterovirus Vaccine Customers
13 MARKET DYNAMICS
13.1 Enterovirus Vaccine Industry Trends
13.2 Enterovirus Vaccine Market Drivers
13.3 Enterovirus Vaccine Market Challenges
13.4 Enterovirus Vaccine Market Restraints
14 KEY FINDINGS IN THE GLOBAL ENTEROVIRUS VACCINE STUDY
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
1.1 Enterovirus Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Enterovirus Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Coxasckievirus A
1.2.3 Coxasckievirus B
1.2.4 Human Enterovirus
1.2.5 Others
1.3 Market by Application
1.3.1 Global Enterovirus Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Research Institute
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Enterovirus Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Enterovirus Vaccine Revenue by Region
2.2.1 Global Enterovirus Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Enterovirus Vaccine Revenue by Region (2018-2023)
2.2.3 Global Enterovirus Vaccine Revenue by Region (2024-2029)
2.2.4 Global Enterovirus Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Enterovirus Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Enterovirus Vaccine Sales by Region
2.4.1 Global Enterovirus Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Enterovirus Vaccine Sales by Region (2018-2023)
2.4.3 Global Enterovirus Vaccine Sales by Region (2024-2029)
2.4.4 Global Enterovirus Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 COMPETITION BY MANUFACTURES
3.1 Global Enterovirus Vaccine Sales by Manufacturers
3.1.1 Global Enterovirus Vaccine Sales by Manufacturers (2018-2023)
3.1.2 Global Enterovirus Vaccine Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Enterovirus Vaccine in 2022
3.2 Global Enterovirus Vaccine Revenue by Manufacturers
3.2.1 Global Enterovirus Vaccine Revenue by Manufacturers (2018-2023)
3.2.2 Global Enterovirus Vaccine Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Enterovirus Vaccine Revenue in 2022
3.3 Global Key Players of Enterovirus Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Enterovirus Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Enterovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Enterovirus Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Enterovirus Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Enterovirus Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE
4.1 Global Enterovirus Vaccine Sales by Type
4.1.1 Global Enterovirus Vaccine Historical Sales by Type (2018-2023)
4.1.2 Global Enterovirus Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Enterovirus Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Enterovirus Vaccine Revenue by Type
4.2.1 Global Enterovirus Vaccine Historical Revenue by Type (2018-2023)
4.2.2 Global Enterovirus Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Enterovirus Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Enterovirus Vaccine Price by Type
4.3.1 Global Enterovirus Vaccine Price by Type (2018-2023)
4.3.2 Global Enterovirus Vaccine Price Forecast by Type (2024-2029)
5 MARKET SIZE BY APPLICATION
5.1 Global Enterovirus Vaccine Sales by Application
5.1.1 Global Enterovirus Vaccine Historical Sales by Application (2018-2023)
5.1.2 Global Enterovirus Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Enterovirus Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Enterovirus Vaccine Revenue by Application
5.2.1 Global Enterovirus Vaccine Historical Revenue by Application (2018-2023)
5.2.2 Global Enterovirus Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Enterovirus Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Enterovirus Vaccine Price by Application
5.3.1 Global Enterovirus Vaccine Price by Application (2018-2023)
5.3.2 Global Enterovirus Vaccine Price Forecast by Application (2024-2029)
6 US & CANADA
6.1 US & Canada Enterovirus Vaccine Market Size by Type
6.1.1 US & Canada Enterovirus Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Enterovirus Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Enterovirus Vaccine Market Size by Application
6.2.1 US & Canada Enterovirus Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Enterovirus Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Enterovirus Vaccine Market Size by Country
6.3.1 US & Canada Enterovirus Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Enterovirus Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Enterovirus Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 EUROPE
7.1 Europe Enterovirus Vaccine Market Size by Type
7.1.1 Europe Enterovirus Vaccine Sales by Type (2018-2029)
7.1.2 Europe Enterovirus Vaccine Revenue by Type (2018-2029)
7.2 Europe Enterovirus Vaccine Market Size by Application
7.2.1 Europe Enterovirus Vaccine Sales by Application (2018-2029)
7.2.2 Europe Enterovirus Vaccine Revenue by Application (2018-2029)
7.3 Europe Enterovirus Vaccine Market Size by Country
7.3.1 Europe Enterovirus Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Enterovirus Vaccine Sales by Country (2018-2029)
7.3.3 Europe Enterovirus Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 CHINA
8.1 China Enterovirus Vaccine Market Size
8.1.1 China Enterovirus Vaccine Sales (2018-2029)
8.1.2 China Enterovirus Vaccine Revenue (2018-2029)
8.2 China Enterovirus Vaccine Market Size by Application
8.2.1 China Enterovirus Vaccine Sales by Application (2018-2029)
8.2.2 China Enterovirus Vaccine Revenue by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Enterovirus Vaccine Market Size by Type
9.1.1 Asia Enterovirus Vaccine Sales by Type (2018-2029)
9.1.2 Asia Enterovirus Vaccine Revenue by Type (2018-2029)
9.2 Asia Enterovirus Vaccine Market Size by Application
9.2.1 Asia Enterovirus Vaccine Sales by Application (2018-2029)
9.2.2 Asia Enterovirus Vaccine Revenue by Application (2018-2029)
9.3 Asia Enterovirus Vaccine Sales by Region
9.3.1 Asia Enterovirus Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Enterovirus Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Enterovirus Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 MIDDLE EAST, AFRICA AND LATIN AMERICA
10.1 Middle East, Africa and Latin America Enterovirus Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Enterovirus Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Enterovirus Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Enterovirus Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Enterovirus Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Enterovirus Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Enterovirus Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Enterovirus Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Enterovirus Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Enterovirus Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 COMPANY PROFILES
11.1 Sinovac Biotech
11.1.1 Sinovac Biotech Company Information
11.1.2 Sinovac Biotech Overview
11.1.3 Sinovac Biotech Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Sinovac Biotech Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sinovac Biotech Recent Developments
11.2 Medigen Vaccine Biologics
11.2.1 Medigen Vaccine Biologics Company Information
11.2.2 Medigen Vaccine Biologics Overview
11.2.3 Medigen Vaccine Biologics Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Medigen Vaccine Biologics Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Medigen Vaccine Biologics Recent Developments
11.3 Shenzhen Neptunus
11.3.1 Shenzhen Neptunus Company Information
11.3.2 Shenzhen Neptunus Overview
11.3.3 Shenzhen Neptunus Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Shenzhen Neptunus Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Shenzhen Neptunus Recent Developments
11.4 Sinopharm
11.4.1 Sinopharm Company Information
11.4.2 Sinopharm Overview
11.4.3 Sinopharm Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Sinopharm Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sinopharm Recent Developments
11.5 Adimmune
11.5.1 Adimmune Company Information
11.5.2 Adimmune Overview
11.5.3 Adimmune Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Adimmune Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Adimmune Recent Developments
11.6 Intravacc
11.6.1 Intravacc Company Information
11.6.2 Intravacc Overview
11.6.3 Intravacc Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Intravacc Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Intravacc Recent Developments
11.7 Shanghai Zerun Biotechnology
11.7.1 Shanghai Zerun Biotechnology Company Information
11.7.2 Shanghai Zerun Biotechnology Overview
11.7.3 Shanghai Zerun Biotechnology Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Shanghai Zerun Biotechnology Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Shanghai Zerun Biotechnology Recent Developments
11.8 Beijing Minhai Biotechnology
11.8.1 Beijing Minhai Biotechnology Company Information
11.8.2 Beijing Minhai Biotechnology Overview
11.8.3 Beijing Minhai Biotechnology Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Beijing Minhai Biotechnology Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Beijing Minhai Biotechnology Recent Developments
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
12.1 Enterovirus Vaccine Industry Chain Analysis
12.2 Enterovirus Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Enterovirus Vaccine Production Mode & Process
12.4 Enterovirus Vaccine Sales and Marketing
12.4.1 Enterovirus Vaccine Sales Channels
12.4.2 Enterovirus Vaccine Distributors
12.5 Enterovirus Vaccine Customers
13 MARKET DYNAMICS
13.1 Enterovirus Vaccine Industry Trends
13.2 Enterovirus Vaccine Market Drivers
13.3 Enterovirus Vaccine Market Challenges
13.4 Enterovirus Vaccine Market Restraints
14 KEY FINDINGS IN THE GLOBAL ENTEROVIRUS VACCINE STUDY
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES
Table 1. Global Enterovirus Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Coxasckievirus A
Table 3. Major Manufacturers of Coxasckievirus B
Table 4. Major Manufacturers of Human Enterovirus 71
Table 5. Major Manufacturers of Others
Table 6. Global Enterovirus Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Enterovirus Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Enterovirus Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global Enterovirus Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Enterovirus Vaccine Revenue Market Share by Region (2018-2023)
Table 11. Global Enterovirus Vaccine Revenue Market Share by Region (2024-2029)
Table 12. Global Enterovirus Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Enterovirus Vaccine Sales by Region (2018-2023) & (K Doses)
Table 14. Global Enterovirus Vaccine Sales by Region (2024-2029) & (K Doses)
Table 15. Global Enterovirus Vaccine Sales Market Share by Region (2018-2023)
Table 16. Global Enterovirus Vaccine Sales Market Share by Region (2024-2029)
Table 17. Global Enterovirus Vaccine Sales by Manufacturers (2018-2023) & (K Doses)
Table 18. Global Enterovirus Vaccine Sales Share by Manufacturers (2018-2023)
Table 19. Global Enterovirus Vaccine Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 20. Global Enterovirus Vaccine Revenue Share by Manufacturers (2018-2023)
Table 21. Global Key Players of Enterovirus Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 22. Enterovirus Vaccine Price by Manufacturers 2018-2023 (US$/Dose)
Table 23. Global Enterovirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Enterovirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enterovirus Vaccine as of 2022)
Table 25. Global Key Manufacturers of Enterovirus Vaccine, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Enterovirus Vaccine, Product Offered and Application
Table 27. Global Key Manufacturers of Enterovirus Vaccine, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Enterovirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 30. Global Enterovirus Vaccine Sales by Type (2024-2029) & (K Doses)
Table 31. Global Enterovirus Vaccine Sales Share by Type (2018-2023)
Table 32. Global Enterovirus Vaccine Sales Share by Type (2024-2029)
Table 33. Global Enterovirus Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 34. Global Enterovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Enterovirus Vaccine Revenue Share by Type (2018-2023)
Table 36. Global Enterovirus Vaccine Revenue Share by Type (2024-2029)
Table 37. Enterovirus Vaccine Price by Type (2018-2023) & (US$/Dose)
Table 38. Global Enterovirus Vaccine Price Forecast by Type (2024-2029) & (US$/Dose)
Table 39. Global Enterovirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 40. Global Enterovirus Vaccine Sales by Application (2024-2029) & (K Doses)
Table 41. Global Enterovirus Vaccine Sales Share by Application (2018-2023)
Table 42. Global Enterovirus Vaccine Sales Share by Application (2024-2029)
Table 43. Global Enterovirus Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 44. Global Enterovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Enterovirus Vaccine Revenue Share by Application (2018-2023)
Table 46. Global Enterovirus Vaccine Revenue Share by Application (2024-2029)
Table 47. Enterovirus Vaccine Price by Application (2018-2023) & (US$/Dose)
Table 48. Global Enterovirus Vaccine Price Forecast by Application (2024-2029) & (US$/Dose)
Table 49. US & Canada Enterovirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 50. US & Canada Enterovirus Vaccine Sales by Type (2024-2029) & (K Doses)
Table 51. US & Canada Enterovirus Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 52. US & Canada Enterovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Enterovirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 54. US & Canada Enterovirus Vaccine Sales by Application (2024-2029) & (K Doses)
Table 55. US & Canada Enterovirus Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 56. US & Canada Enterovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Enterovirus Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Enterovirus Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 59. US & Canada Enterovirus Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Enterovirus Vaccine Sales by Country (2018-2023) & (K Doses)
Table 61. US & Canada Enterovirus Vaccine Sales by Country (2024-2029) & (K Doses)
Table 62. Europe Enterovirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 63. Europe Enterovirus Vaccine Sales by Type (2024-2029) & (K Doses)
Table 64. Europe Enterovirus Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 65. Europe Enterovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Enterovirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 67. Europe Enterovirus Vaccine Sales by Application (2024-2029) & (K Doses)
Table 68. Europe Enterovirus Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 69. Europe Enterovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Enterovirus Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Enterovirus Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 72. Europe Enterovirus Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Enterovirus Vaccine Sales by Country (2018-2023) & (K Doses)
Table 74. Europe Enterovirus Vaccine Sales by Country (2024-2029) & (K Doses)
Table 75. China Enterovirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 76. China Enterovirus Vaccine Sales by Type (2024-2029) & (K Doses)
Table 77. China Enterovirus Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 78. China Enterovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Enterovirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 80. China Enterovirus Vaccine Sales by Application (2024-2029) & (K Doses)
Table 81. China Enterovirus Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 82. China Enterovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Enterovirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 84. Asia Enterovirus Vaccine Sales by Type (2024-2029) & (K Doses)
Table 85. Asia Enterovirus Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 86. Asia Enterovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Enterovirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 88. Asia Enterovirus Vaccine Sales by Application (2024-2029) & (K Doses)
Table 89. Asia Enterovirus Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 90. Asia Enterovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Enterovirus Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Enterovirus Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 93. Asia Enterovirus Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Enterovirus Vaccine Sales by Region (2018-2023) & (K Doses)
Table 95. Asia Enterovirus Vaccine Sales by Region (2024-2029) & (K Doses)
Table 96. Middle East, Africa and Latin America Enterovirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 97. Middle East, Africa and Latin America Enterovirus Vaccine Sales by Type (2024-2029) & (K Doses)
Table 98. Middle East, Africa and Latin America Enterovirus Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 99. Middle East, Africa and Latin America Enterovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Enterovirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 101. Middle East, Africa and Latin America Enterovirus Vaccine Sales by Application (2024-2029) & (K Doses)
Table 102. Middle East, Africa and Latin America Enterovirus Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 103. Middle East, Africa and Latin America Enterovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Enterovirus Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Enterovirus Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America Enterovirus Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Enterovirus Vaccine Sales by Country (2018-2023) & (K Doses)
Table 108. Middle East, Africa and Latin America Enterovirus Vaccine Sales by Country (2024-2029) & (K Doses)
Table 109. Sinovac Biotech Company Information
Table 110. Sinovac Biotech Description and Major Businesses
Table 111. Sinovac Biotech Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 112. Sinovac Biotech Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Sinovac Biotech Recent Developments
Table 114. Medigen Vaccine Biologics Company Information
Table 115. Medigen Vaccine Biologics Description and Major Businesses
Table 116. Medigen Vaccine Biologics Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 117. Medigen Vaccine Biologics Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Medigen Vaccine Biologics Recent Developments
Table 119. Shenzhen Neptunus Company Information
Table 120. Shenzhen Neptunus Description and Major Businesses
Table 121. Shenzhen Neptunus Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 122. Shenzhen Neptunus Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Shenzhen Neptunus Recent Developments
Table 124. Sinopharm Company Information
Table 125. Sinopharm Description and Major Businesses
Table 126. Sinopharm Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 127. Sinopharm Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Sinopharm Recent Developments
Table 129. Adimmune Company Information
Table 130. Adimmune Description and Major Businesses
Table 131. Adimmune Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 132. Adimmune Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Adimmune Recent Developments
Table 134. Intravacc Company Information
Table 135. Intravacc Description and Major Businesses
Table 136. Intravacc Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 137. Intravacc Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Intravacc Recent Developments
Table 139. Shanghai Zerun Biotechnology Company Information
Table 140. Shanghai Zerun Biotechnology Description and Major Businesses
Table 141. Shanghai Zerun Biotechnology Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 142. Shanghai Zerun Biotechnology Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Shanghai Zerun Biotechnology Recent Developments
Table 144. Beijing Minhai Biotechnology Company Information
Table 145. Beijing Minhai Biotechnology Description and Major Businesses
Table 146. Beijing Minhai Biotechnology Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 147. Beijing Minhai Biotechnology Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Beijing Minhai Biotechnology Recent Developments
Table 149. Key Raw Materials Lists
Table 150. Raw Materials Key Suppliers Lists
Table 151. Enterovirus Vaccine Distributors List
Table 152. Enterovirus Vaccine Customers List
Table 153. Enterovirus Vaccine Market Trends
Table 154. Enterovirus Vaccine Market Drivers
Table 155. Enterovirus Vaccine Market Challenges
Table 156. Enterovirus Vaccine Market Restraints
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
Table 1. Global Enterovirus Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Coxasckievirus A
Table 3. Major Manufacturers of Coxasckievirus B
Table 4. Major Manufacturers of Human Enterovirus 71
Table 5. Major Manufacturers of Others
Table 6. Global Enterovirus Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Enterovirus Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Enterovirus Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global Enterovirus Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Enterovirus Vaccine Revenue Market Share by Region (2018-2023)
Table 11. Global Enterovirus Vaccine Revenue Market Share by Region (2024-2029)
Table 12. Global Enterovirus Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Enterovirus Vaccine Sales by Region (2018-2023) & (K Doses)
Table 14. Global Enterovirus Vaccine Sales by Region (2024-2029) & (K Doses)
Table 15. Global Enterovirus Vaccine Sales Market Share by Region (2018-2023)
Table 16. Global Enterovirus Vaccine Sales Market Share by Region (2024-2029)
Table 17. Global Enterovirus Vaccine Sales by Manufacturers (2018-2023) & (K Doses)
Table 18. Global Enterovirus Vaccine Sales Share by Manufacturers (2018-2023)
Table 19. Global Enterovirus Vaccine Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 20. Global Enterovirus Vaccine Revenue Share by Manufacturers (2018-2023)
Table 21. Global Key Players of Enterovirus Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 22. Enterovirus Vaccine Price by Manufacturers 2018-2023 (US$/Dose)
Table 23. Global Enterovirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Enterovirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enterovirus Vaccine as of 2022)
Table 25. Global Key Manufacturers of Enterovirus Vaccine, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Enterovirus Vaccine, Product Offered and Application
Table 27. Global Key Manufacturers of Enterovirus Vaccine, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Enterovirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 30. Global Enterovirus Vaccine Sales by Type (2024-2029) & (K Doses)
Table 31. Global Enterovirus Vaccine Sales Share by Type (2018-2023)
Table 32. Global Enterovirus Vaccine Sales Share by Type (2024-2029)
Table 33. Global Enterovirus Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 34. Global Enterovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Enterovirus Vaccine Revenue Share by Type (2018-2023)
Table 36. Global Enterovirus Vaccine Revenue Share by Type (2024-2029)
Table 37. Enterovirus Vaccine Price by Type (2018-2023) & (US$/Dose)
Table 38. Global Enterovirus Vaccine Price Forecast by Type (2024-2029) & (US$/Dose)
Table 39. Global Enterovirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 40. Global Enterovirus Vaccine Sales by Application (2024-2029) & (K Doses)
Table 41. Global Enterovirus Vaccine Sales Share by Application (2018-2023)
Table 42. Global Enterovirus Vaccine Sales Share by Application (2024-2029)
Table 43. Global Enterovirus Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 44. Global Enterovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Enterovirus Vaccine Revenue Share by Application (2018-2023)
Table 46. Global Enterovirus Vaccine Revenue Share by Application (2024-2029)
Table 47. Enterovirus Vaccine Price by Application (2018-2023) & (US$/Dose)
Table 48. Global Enterovirus Vaccine Price Forecast by Application (2024-2029) & (US$/Dose)
Table 49. US & Canada Enterovirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 50. US & Canada Enterovirus Vaccine Sales by Type (2024-2029) & (K Doses)
Table 51. US & Canada Enterovirus Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 52. US & Canada Enterovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Enterovirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 54. US & Canada Enterovirus Vaccine Sales by Application (2024-2029) & (K Doses)
Table 55. US & Canada Enterovirus Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 56. US & Canada Enterovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Enterovirus Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Enterovirus Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 59. US & Canada Enterovirus Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Enterovirus Vaccine Sales by Country (2018-2023) & (K Doses)
Table 61. US & Canada Enterovirus Vaccine Sales by Country (2024-2029) & (K Doses)
Table 62. Europe Enterovirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 63. Europe Enterovirus Vaccine Sales by Type (2024-2029) & (K Doses)
Table 64. Europe Enterovirus Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 65. Europe Enterovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Enterovirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 67. Europe Enterovirus Vaccine Sales by Application (2024-2029) & (K Doses)
Table 68. Europe Enterovirus Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 69. Europe Enterovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Enterovirus Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Enterovirus Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 72. Europe Enterovirus Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Enterovirus Vaccine Sales by Country (2018-2023) & (K Doses)
Table 74. Europe Enterovirus Vaccine Sales by Country (2024-2029) & (K Doses)
Table 75. China Enterovirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 76. China Enterovirus Vaccine Sales by Type (2024-2029) & (K Doses)
Table 77. China Enterovirus Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 78. China Enterovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Enterovirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 80. China Enterovirus Vaccine Sales by Application (2024-2029) & (K Doses)
Table 81. China Enterovirus Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 82. China Enterovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Enterovirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 84. Asia Enterovirus Vaccine Sales by Type (2024-2029) & (K Doses)
Table 85. Asia Enterovirus Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 86. Asia Enterovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Enterovirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 88. Asia Enterovirus Vaccine Sales by Application (2024-2029) & (K Doses)
Table 89. Asia Enterovirus Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 90. Asia Enterovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Enterovirus Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Enterovirus Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 93. Asia Enterovirus Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Enterovirus Vaccine Sales by Region (2018-2023) & (K Doses)
Table 95. Asia Enterovirus Vaccine Sales by Region (2024-2029) & (K Doses)
Table 96. Middle East, Africa and Latin America Enterovirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 97. Middle East, Africa and Latin America Enterovirus Vaccine Sales by Type (2024-2029) & (K Doses)
Table 98. Middle East, Africa and Latin America Enterovirus Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 99. Middle East, Africa and Latin America Enterovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Enterovirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 101. Middle East, Africa and Latin America Enterovirus Vaccine Sales by Application (2024-2029) & (K Doses)
Table 102. Middle East, Africa and Latin America Enterovirus Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 103. Middle East, Africa and Latin America Enterovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Enterovirus Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Enterovirus Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America Enterovirus Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Enterovirus Vaccine Sales by Country (2018-2023) & (K Doses)
Table 108. Middle East, Africa and Latin America Enterovirus Vaccine Sales by Country (2024-2029) & (K Doses)
Table 109. Sinovac Biotech Company Information
Table 110. Sinovac Biotech Description and Major Businesses
Table 111. Sinovac Biotech Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 112. Sinovac Biotech Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Sinovac Biotech Recent Developments
Table 114. Medigen Vaccine Biologics Company Information
Table 115. Medigen Vaccine Biologics Description and Major Businesses
Table 116. Medigen Vaccine Biologics Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 117. Medigen Vaccine Biologics Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Medigen Vaccine Biologics Recent Developments
Table 119. Shenzhen Neptunus Company Information
Table 120. Shenzhen Neptunus Description and Major Businesses
Table 121. Shenzhen Neptunus Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 122. Shenzhen Neptunus Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Shenzhen Neptunus Recent Developments
Table 124. Sinopharm Company Information
Table 125. Sinopharm Description and Major Businesses
Table 126. Sinopharm Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 127. Sinopharm Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Sinopharm Recent Developments
Table 129. Adimmune Company Information
Table 130. Adimmune Description and Major Businesses
Table 131. Adimmune Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 132. Adimmune Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Adimmune Recent Developments
Table 134. Intravacc Company Information
Table 135. Intravacc Description and Major Businesses
Table 136. Intravacc Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 137. Intravacc Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Intravacc Recent Developments
Table 139. Shanghai Zerun Biotechnology Company Information
Table 140. Shanghai Zerun Biotechnology Description and Major Businesses
Table 141. Shanghai Zerun Biotechnology Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 142. Shanghai Zerun Biotechnology Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Shanghai Zerun Biotechnology Recent Developments
Table 144. Beijing Minhai Biotechnology Company Information
Table 145. Beijing Minhai Biotechnology Description and Major Businesses
Table 146. Beijing Minhai Biotechnology Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 147. Beijing Minhai Biotechnology Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Beijing Minhai Biotechnology Recent Developments
Table 149. Key Raw Materials Lists
Table 150. Raw Materials Key Suppliers Lists
Table 151. Enterovirus Vaccine Distributors List
Table 152. Enterovirus Vaccine Customers List
Table 153. Enterovirus Vaccine Market Trends
Table 154. Enterovirus Vaccine Market Drivers
Table 155. Enterovirus Vaccine Market Challenges
Table 156. Enterovirus Vaccine Market Restraints
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Enterovirus Vaccine Product Picture
Figure 2. Global Enterovirus Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Enterovirus Vaccine Market Share by Type in 2022 & 2029
Figure 4. Coxasckievirus A Product Picture
Figure 5. Coxasckievirus B Product Picture
Figure 6. Human Enterovirus 71 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Enterovirus Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Enterovirus Vaccine Market Share by Application in 2022 & 2029
Figure 10. Hospital
Figure 11. Research Institute
Figure 12. Others
Figure 13. Enterovirus Vaccine Report Years Considered
Figure 14. Global Enterovirus Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Enterovirus Vaccine Revenue 2018-2029 (US$ Million)
Figure 16. Global Enterovirus Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Enterovirus Vaccine Revenue Market Share by Region (2018-2029)
Figure 18. Global Enterovirus Vaccine Sales 2018-2029 ((K Doses)
Figure 19. Global Enterovirus Vaccine Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Enterovirus Vaccine Sales YoY (2018-2029) & (K Doses)
Figure 21. US & Canada Enterovirus Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Enterovirus Vaccine Sales YoY (2018-2029) & (K Doses)
Figure 23. Europe Enterovirus Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Enterovirus Vaccine Sales YoY (2018-2029) & (K Doses)
Figure 25. China Enterovirus Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Enterovirus Vaccine Sales YoY (2018-2029) & (K Doses)
Figure 27. Asia (excluding China) Enterovirus Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Enterovirus Vaccine Sales YoY (2018-2029) & (K Doses)
Figure 29. Middle East, Africa and Latin America Enterovirus Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Enterovirus Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Enterovirus Vaccine in the World: Market Share by Enterovirus Vaccine Revenue in 2022
Figure 32. Global Enterovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Enterovirus Vaccine Sales Market Share by Type (2018-2029)
Figure 34. Global Enterovirus Vaccine Revenue Market Share by Type (2018-2029)
Figure 35. Global Enterovirus Vaccine Sales Market Share by Application (2018-2029)
Figure 36. Global Enterovirus Vaccine Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Enterovirus Vaccine Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Enterovirus Vaccine Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Enterovirus Vaccine Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Enterovirus Vaccine Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Enterovirus Vaccine Revenue Share by Country (2018-2029)
Figure 42. US & Canada Enterovirus Vaccine Sales Share by Country (2018-2029)
Figure 43. U.S. Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Enterovirus Vaccine Sales Market Share by Type (2018-2029)
Figure 46. Europe Enterovirus Vaccine Revenue Market Share by Type (2018-2029)
Figure 47. Europe Enterovirus Vaccine Sales Market Share by Application (2018-2029)
Figure 48. Europe Enterovirus Vaccine Revenue Market Share by Application (2018-2029)
Figure 49. Europe Enterovirus Vaccine Revenue Share by Country (2018-2029)
Figure 50. Europe Enterovirus Vaccine Sales Share by Country (2018-2029)
Figure 51. Germany Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. France Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 56. China Enterovirus Vaccine Sales Market Share by Type (2018-2029)
Figure 57. China Enterovirus Vaccine Revenue Market Share by Type (2018-2029)
Figure 58. China Enterovirus Vaccine Sales Market Share by Application (2018-2029)
Figure 59. China Enterovirus Vaccine Revenue Market Share by Application (2018-2029)
Figure 60. Asia Enterovirus Vaccine Sales Market Share by Type (2018-2029)
Figure 61. Asia Enterovirus Vaccine Revenue Market Share by Type (2018-2029)
Figure 62. Asia Enterovirus Vaccine Sales Market Share by Application (2018-2029)
Figure 63. Asia Enterovirus Vaccine Revenue Market Share by Application (2018-2029)
Figure 64. Asia Enterovirus Vaccine Revenue Share by Region (2018-2029)
Figure 65. Asia Enterovirus Vaccine Sales Share by Region (2018-2029)
Figure 66. Japan Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 70. India Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Enterovirus Vaccine Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Enterovirus Vaccine Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Enterovirus Vaccine Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Enterovirus Vaccine Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Enterovirus Vaccine Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Enterovirus Vaccine Sales Share by Country (2018-2029)
Figure 77. Brazil Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 82. Enterovirus Vaccine Value Chain
Figure 83. Enterovirus Vaccine Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
Figure 1. Enterovirus Vaccine Product Picture
Figure 2. Global Enterovirus Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Enterovirus Vaccine Market Share by Type in 2022 & 2029
Figure 4. Coxasckievirus A Product Picture
Figure 5. Coxasckievirus B Product Picture
Figure 6. Human Enterovirus 71 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Enterovirus Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Enterovirus Vaccine Market Share by Application in 2022 & 2029
Figure 10. Hospital
Figure 11. Research Institute
Figure 12. Others
Figure 13. Enterovirus Vaccine Report Years Considered
Figure 14. Global Enterovirus Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Enterovirus Vaccine Revenue 2018-2029 (US$ Million)
Figure 16. Global Enterovirus Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Enterovirus Vaccine Revenue Market Share by Region (2018-2029)
Figure 18. Global Enterovirus Vaccine Sales 2018-2029 ((K Doses)
Figure 19. Global Enterovirus Vaccine Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Enterovirus Vaccine Sales YoY (2018-2029) & (K Doses)
Figure 21. US & Canada Enterovirus Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Enterovirus Vaccine Sales YoY (2018-2029) & (K Doses)
Figure 23. Europe Enterovirus Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Enterovirus Vaccine Sales YoY (2018-2029) & (K Doses)
Figure 25. China Enterovirus Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Enterovirus Vaccine Sales YoY (2018-2029) & (K Doses)
Figure 27. Asia (excluding China) Enterovirus Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Enterovirus Vaccine Sales YoY (2018-2029) & (K Doses)
Figure 29. Middle East, Africa and Latin America Enterovirus Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Enterovirus Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Enterovirus Vaccine in the World: Market Share by Enterovirus Vaccine Revenue in 2022
Figure 32. Global Enterovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Enterovirus Vaccine Sales Market Share by Type (2018-2029)
Figure 34. Global Enterovirus Vaccine Revenue Market Share by Type (2018-2029)
Figure 35. Global Enterovirus Vaccine Sales Market Share by Application (2018-2029)
Figure 36. Global Enterovirus Vaccine Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Enterovirus Vaccine Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Enterovirus Vaccine Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Enterovirus Vaccine Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Enterovirus Vaccine Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Enterovirus Vaccine Revenue Share by Country (2018-2029)
Figure 42. US & Canada Enterovirus Vaccine Sales Share by Country (2018-2029)
Figure 43. U.S. Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Enterovirus Vaccine Sales Market Share by Type (2018-2029)
Figure 46. Europe Enterovirus Vaccine Revenue Market Share by Type (2018-2029)
Figure 47. Europe Enterovirus Vaccine Sales Market Share by Application (2018-2029)
Figure 48. Europe Enterovirus Vaccine Revenue Market Share by Application (2018-2029)
Figure 49. Europe Enterovirus Vaccine Revenue Share by Country (2018-2029)
Figure 50. Europe Enterovirus Vaccine Sales Share by Country (2018-2029)
Figure 51. Germany Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. France Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 56. China Enterovirus Vaccine Sales Market Share by Type (2018-2029)
Figure 57. China Enterovirus Vaccine Revenue Market Share by Type (2018-2029)
Figure 58. China Enterovirus Vaccine Sales Market Share by Application (2018-2029)
Figure 59. China Enterovirus Vaccine Revenue Market Share by Application (2018-2029)
Figure 60. Asia Enterovirus Vaccine Sales Market Share by Type (2018-2029)
Figure 61. Asia Enterovirus Vaccine Revenue Market Share by Type (2018-2029)
Figure 62. Asia Enterovirus Vaccine Sales Market Share by Application (2018-2029)
Figure 63. Asia Enterovirus Vaccine Revenue Market Share by Application (2018-2029)
Figure 64. Asia Enterovirus Vaccine Revenue Share by Region (2018-2029)
Figure 65. Asia Enterovirus Vaccine Sales Share by Region (2018-2029)
Figure 66. Japan Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 70. India Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Enterovirus Vaccine Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Enterovirus Vaccine Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Enterovirus Vaccine Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Enterovirus Vaccine Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Enterovirus Vaccine Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Enterovirus Vaccine Sales Share by Country (2018-2029)
Figure 77. Brazil Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Enterovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 82. Enterovirus Vaccine Value Chain
Figure 83. Enterovirus Vaccine Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
